Trials / Completed
CompletedNCT00810472
Functional Antigen Matching in Corneal Transplantation
Clinical Trial to Investigate Superiority of HLA Matching in Comparison to Random Graft Assignment With Respect to the Endpoint 'Time to First Endothelial Graft Rejection' in Penetrating Keratoplasty.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 650 (estimated)
- Sponsor
- University Hospital Freiburg · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Penetrating keratoplasty is one of the most commonly performed transplantation surgeries. Graft rejection is a major complication. HLA compatibility has already been demonstrated an effective prophylaxis in several retrospective investigations. The purpose of the investigators randomized clinical trial is to demonstrate superiority of HLA matching in comparison to random graft assignment with respect to the endpoint 'time to first endothelial graft rejection' in penetrating keratoplasty. The investigators will perform DNA-based allele resolution typing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | HLA Matching | HLA matching is exerted by selecting the donor with least-most additional HLA alleles. We will predict the waiting time for such a donor in order to assess eligibility for the trial \[8\]. In addition, we will dynamically adopt the degree of matching that is aimed at depending on the predicted time interval and actual waiting time: the first donors not exerting more than 7 mismatches at the triplet-amino-acid-residue-level (HLAMatchmaker method \[6\]) is accepted if the patient is waiting less than half of his predicted waiting time. The next available donor exerting a 2/6 match (or better) is assigned thereafter. The next graft will be assigned, regardless of HLA matching after 6 months. |
| PROCEDURE | Penetrating keratoplasty | Corneal transplantation. |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2008-12-18
- Last updated
- 2016-10-25
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00810472. Inclusion in this directory is not an endorsement.